Nigella sativa in the Management of Type 2 Diabetes Mellitus: A Review of Contemporary Pharmacological Evidence and the Prophetic Medicine (Tibb al-Nabawi) Tradition

Type 2 diabetes mellitus (T2DM) is a growing global health burden, and many patients use complementary agents alongside standard therapy. Nigella sativa L. (black seed, habbatu sawda) is among the most widely used of these, and it is prominent in the Prophetic medicine (Tibb al-Nabawi) tradition. The scientific and traditional literatures have rarely been examined together in a way that keeps their evidentiary standards distinct. This study aimed to critically appraise the preclinical and clinical evidence for N. sativa and its principal constituent thymoquinone (TQ) in T2DM, to examine how the Prophetic medicine tradition characterises black seed, and to assess where the two bodies of knowledge converge and diverge. An integrative narrative review was designed following SANRA quality criteria, with a search of PubMed, Scopus, Web of Science, and Embase for pharmacological literature, and a source-critical reading of authenticated hadith collections and classical medical texts for the traditional literature. Preclinical work consistently shows that N. sativa preparations and TQ improve glycaemic indices through several mechanisms. These include enhanced glucose-stimulated insulin secretion, reduced hepatic gluconeogenesis, improved peripheral insulin signalling, reduced intestinal glucose absorption, and attenuation of oxidative and inflammatory stress. Meta-analyses of randomised controlled trials, including those published in 2024–2026, report statistically significant reductions in fasting glucose and glycated haemoglobin (HbA1c), by about 0.4– 0.6 percentage points were reported in natural units, with no consistent effect on insulin or HOMA-IR, but trials are small, short, and heterogeneous in preparation, dose, and quality. The Prophetic tradition presents black seed as a broad-spectrum remedy and does not address T2DM specifically, so any link to diabetes is an interpretive extension. N. sativa is a promising adjunct, not a replacement, for standard T2DM care. The tradition supports cultural acceptability and a plausible prior for benefit, while the pharmacological evidence has to stand on its own methodological merits. Standardised preparations, larger and longer trials, pharmacokinetic work on TQ, and herb-drug interaction studies are priorities.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-14
DOI
https://doi.org/10.5281/zenodo.24214733
Primary Topic
Nigella sativa pharmacological applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Nigella sativa in the Management of Type 2 Diabetes Mellitus: A Review of Contemporary Pharmacological Evidence and the Prophetic Medicine (Tibb al-Nabawi) Tradition

Fatima Abubakar Gidadawa, Shehu Usman Abdullahi, Gunnjeet Kaur
Zenodo (CERN European Organization for Nuclear Research)
Nigella sativa pharmacological applications
article

Nigella sativa in the Management of Type 2 Diabetes Mellitus: A Review of Contemporary Pharmacological Evidence and the Prophetic Medicine (Tibb al-Nabawi) Tradition

Fatima Abubakar Gidadawa, Shehu Usman Abdullahi, Gunnjeet Kaur
article en

Abstract

Type 2 diabetes mellitus (T2DM) is a growing global health burden, and many patients use complementary agents alongside standard therapy. Nigella sativa L. (black seed, habbatu sawda) is among the most widely used of these, and it is prominent in the Prophetic medicine (Tibb al-Nabawi) tradition. The scientific and traditional literatures have rarely been examined together in a way that keeps their evidentiary standards distinct. This study aimed to critically appraise the preclinical and clinical evidence for N. sativa and its principal constituent thymoquinone (TQ) in T2DM, to examine how the Prophetic medicine tradition characterises black seed, and to assess where the two bodies of knowledge converge and diverge. An integrative narrative review was designed following SANRA quality criteria, with a search of PubMed, Scopus, Web of Science, and Embase for pharmacological literature, and a source-critical reading of authenticated hadith collections and classical medical texts for the traditional literature. Preclinical work consistently shows that N. sativa preparations and TQ improve glycaemic indices through several mechanisms. These include enhanced glucose-stimulated insulin secretion, reduced hepatic gluconeogenesis, improved peripheral insulin signalling, reduced intestinal glucose absorption, and attenuation of oxidative and inflammatory stress. Meta-analyses of randomised controlled trials, including those published in 2024–2026, report statistically significant reductions in fasting glucose and glycated haemoglobin (HbA1c), by about 0.4– 0.6 percentage points were reported in natural units, with no consistent effect on insulin or HOMA-IR, but trials are small, short, and heterogeneous in preparation, dose, and quality. The Prophetic tradition presents black seed as a broad-spectrum remedy and does not address T2DM specifically, so any link to diabetes is an interpretive extension. N. sativa is a promising adjunct, not a replacement, for standard T2DM care. The tradition supports cultural acceptability and a plausible prior for benefit, while the pharmacological evidence has to stand on its own methodological merits. Standardised preparations, larger and longer trials, pharmacokinetic work on TQ, and herb-drug interaction studies are priorities.

Zenodo (CERN European Organization for Nuclear Research)
Nigella sativa pharmacological applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon